Literature DB >> 9573004

Lymphohematopoietic engraftment in minimally myeloablated hosts.

F M Stewart1, S Zhong, J Wuu, C Hsieh, S K Nilsson, P J Quesenberry.   

Abstract

The concept that myeloablation to open space was a prerequisite for marrow stem cell engraftment has been challenged by studies showing high rates of engraftment in nonmyeloablated mice (Stewart et al, Blood 81:2566, 1993; Quesenberry et al, Blood Cells 20:97, 1994; Brecher et al, Blood Cells 5:237, 1979; Saxe et al, Exp Hematol 12:277, 1984; and Wu et al, Exp Hematol 21:251, 1993). However, relatively large numbers of marrow cells were necessary to achieve high long-term donor percentages. We have demonstrated, using a BALB/c male/female marrow transplant model and detecting male DNA in host tissues by Southern blot or fluorescent in situ hybridization, that exposure to doses of irradiation that cause minimal myeloablation (50 to 100 cGy) leads to very high levels of donor chimerism, such that relatively small numbers of marrow cells (10 to 40 million) can give donor chimerism in the 40% to 100% range. Studies of radiation sensitivity of long-term engrafting cells have shown that 100 cGy, although not myelotoxic, is stem cell toxic, and indicate that the final host:donor ratios are determined by competition between host and donor stem cells. These data indicate that low levels of irradiation should be an effective approach to nontoxic marrow transplantation in gene therapy or in attempts to create allochimerism to treat such diseases as cancer, sickle cell anemia, or thalassemia.

Entities:  

Mesh:

Year:  1998        PMID: 9573004

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  25 in total

1.  The new stem cell biology.

Authors:  Peter J Quesenberry; Gerald A Colvin; Jean-Francois Lambert; Angela E Frimberger; Mark S Dooner; Christina I Mcauliffe; Caroline Miller; Pamela Becker; Evangelis Badiavas; Vincent J Falanga; Gerald Elfenbein; Lawrence G Lum
Journal:  Trans Am Clin Climatol Assoc       Date:  2002

Review 2.  Hematopoietic-stem-cell-based gene therapy for HIV disease.

Authors:  Hans-Peter Kiem; Keith R Jerome; Steven G Deeks; Joseph M McCune
Journal:  Cell Stem Cell       Date:  2012-02-03       Impact factor: 24.633

Review 3.  Survival of the fittest: in vivo selection and stem cell gene therapy.

Authors:  Tobias Neff; Brian C Beard; Hans-Peter Kiem
Journal:  Blood       Date:  2005-11-03       Impact factor: 22.113

4.  Mobilization as a preparative regimen for hematopoietic stem cell transplantation.

Authors:  Jing Chen; André Larochelle; Simon Fricker; Gary Bridger; Cynthia E Dunbar; Janis L Abkowitz
Journal:  Blood       Date:  2006-01-26       Impact factor: 22.113

5.  A non-myeloablative conditioning approach for long-term engraftment of human and mouse hematopoietic stem cells.

Authors:  Wei Du; Wei Liu; Benjamin Mizukawa; Xun Shang; Jared Sipple; Mark Wunderlich; Hartmut Geiger; Stella Davies; James Mulloy; Qishen Pang; Yi Zheng
Journal:  Leukemia       Date:  2018-06-29       Impact factor: 11.528

Review 6.  Stem cell homing: rolling, crawling, and nesting.

Authors:  P J Quesenberry; P S Becker
Journal:  Proc Natl Acad Sci U S A       Date:  1998-12-22       Impact factor: 11.205

7.  Stable mixed chimerism and tolerance using a nonmyeloablative preparative regimen in a large-animal model.

Authors:  C A Huang; Y Fuchimoto; R Scheier-Dolberg; M C Murphy; D M Neville; D H Sachs
Journal:  J Clin Invest       Date:  2000-01       Impact factor: 14.808

Review 8.  To condition or not to condition-That is the question: The evolution of nonmyeloablative conditions for transplantation.

Authors:  Anna Rita Migliaccio
Journal:  Exp Hematol       Date:  2016-05-06       Impact factor: 3.084

Review 9.  Low dose total body irradiation followed by allogeneic lymphocyte infusion for refractory hematologic malignancy--an updated review.

Authors:  Karen K Ballen; Gerald Colvin; David Porter; Peter J Quesenberry
Journal:  Leuk Lymphoma       Date:  2004-05

10.  Niche recycling through division-independent egress of hematopoietic stem cells.

Authors:  Deepta Bhattacharya; Agnieszka Czechowicz; A G Lisa Ooi; Derrick J Rossi; David Bryder; Irving L Weissman
Journal:  J Exp Med       Date:  2009-11-02       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.